(Q41697392)

7 October 2017

1 reference

title

Gastrointestinal diseases in women (English)

1 reference

7 October 2017

Borum ML

1

1 reference

7 October 2017

publication date

1 January 1998

1 reference

Medical Clinics of North America

7 October 2017

published in

1 reference

7 October 2017

volume

82

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

21-50

1 reference

Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

A fresh look at pregnancy heartburn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Haematological adverse effects of histamine H2-receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Uveitis occurring after colectomy and ileal-rectal sleeve anastomosis for ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Food hypersensitivity in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Person-to-person transmission of Campylobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

A double-blind controlled trial of ‘Gaviscon’ in patients with symptomatic gastro-oesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Primary care of women with gastrointestinal disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Trends in incidence rates of ulcerative colitis and Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The lower esophageal sphincter. Physiologic and clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Nonassociation of Adrenocorticosteroid Therapy and Peptic Ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Diagnostic procedures in irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Functional abdominal pain, psychiatric illness, and life events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Clinical Pharmacokinetics of Sulphasalazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Ulcerative colitis and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Nephrolithiasis as a complication of ulcerative colitis and regional enteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Effect of smoking on the production and maintenance of gastric and duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Sexual and physical abuse in women with functional or organic gastrointestinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The irritable bowel syndrome: review and a graduated multicomponent treatment approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Intrafamilial clustering of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

Esophageal Hiatal Hernia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Life events, psychiatric illness and the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The musculo-skeletal complications of Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Metoclopramide and the gastro-oesophageal sphincter. A study in pregnant women with heartburn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The gastroesophageal scintiscan. Comparison of methods to demonstrate gastroesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Changing clinical pattern of gastric ulcer: are anti-inflammatory drugs involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Irritable bowel syndrome in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Crohn's disease and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Implications of sucralfate-induced ulcer healing and relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Sucralfate Overcomes Adverse Effect of Cigarette Smoking on Duodenal Ulcer Healing and Prolongs Subsequent Remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Psychological aspects of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Clinical review of histamine2 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Psyllium therapy in the irritable bowel syndrome. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Transmission of Helicobacter pylori infection. Studies in families of healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Do non-steroidal anti-inflammatory drugs or smoking predispose to Helicobacter pylori infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Safety of Cimetidine in Obstetric Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Association of Adrenocorticosteroid Therapy and Peptic-Ulcer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

PERICHOLANGITIS AND ULCERATIVE COLITIS. I. PATHOLOGY, ETIOLOGY, AND PATHOGENESIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Symptomatic gastroesophageal reflux: incidence and precipitating factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Reflux Esophagitis: Radiographic and Endoscopic Correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Natural history of gastro-oesophageal reflux disease without oesophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Healing of duodenal ulcer with an antacid regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Pregnancy in the patient with ileostomy and colectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Gastric H+,K(+)-ATPase as a therapeutic target in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Epidemiology of irritable bowel syndrome in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Late outcome of bleeding gastric ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Gastro-oesophageal reflux in the irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Prevalence of oesophagitis in asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Ulcerative proctitis and mild ulcerative colitis: A study of 220 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Irritable bowel syndrome: pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Rising frequency of ulcer perforation in elderly people in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Ulcerative Colitis in Pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Biofeedback treatment of gastrointestinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Non-colonic features of irritable bowel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

A controlled trial of psychological treatment for the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

Determinants of pregnancy heartburn

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970593-9

7 January 2021

10.1016/S0025-7125(05)70593-9

Identifiers

DOI

1 reference

7 October 2017

1 reference